The iconic rise of Viagra has firmly established as a example of pharmaceutical success, but its position within the broader sector now presents questions about future returns . Copycat versions are eroding patent protection , prompting anxieties that supporting companies heavily reliant to Viagra's previous position could be a speculative move , e